Surgery versus radioiodine therapy as definitive management for Graves' disease: The role of patient preference

Thyroid

Volumn 17, Issue 2, 2007, Pages 157-160

  Grodski, Simon ^a   Stalberg, Peter ^a   Robinson, Bruce G ^a   Delbridge, Leigh W ^a,b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b ROYAL NORTH SHORE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHYROID AGENT; LUGOL; RADIOACTIVE IODINE;

ADOLESCENT; ADULT; ARTICLE; COHORT ANALYSIS; COMPARATIVE STUDY; ENDOCRINE OPHTHALMOPATHY; FEMALE; GOITER; GRAVES DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT ATTITUDE; PATIENT SATISFACTION; PRIORITY JOURNAL; QUESTIONNAIRE; RETROSPECTIVE STUDY; SURGEON; THYROID NODULE; THYROIDECTOMY; TREATMENT INDICATION; TREATMENT OUTCOME; TREATMENT PLANNING; VISUAL ANALOG SCALE;

ADOLESCENT; ADULT; COHORT STUDIES; FEMALE; GRAVES DISEASE; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; PATIENT SATISFACTION; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; THYROIDECTOMY;

EID: 33847645088     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2006.0141     Document Type: Article

References (17)

1. Alsanea O, Clark OH 2000 Treatment of Graves' disease: the advantages of surgery. Endocrinol Metab Clin North Am 29:321-337.
2. Schussler-Fiorenza CM, Burns CM, Chen H 2006 The surgical management of Graves' disease. J Surg Res 133(2): 207-214.
3. Delbridge L 2003 Total thyroidectomy: the evolution of surgical technique. ANZ J Surg 73:761-768.
4. Barakate MS, Agarwal G, Reeve TS, Barraclough B, Robinson B, Delbridge LW 2002 Total thyroidectomy is now the preferred option for the surgical management of Graves' disease. ANZ J Surg 72:321-324.
5. Ku CF, Lo CY, Chan WF, Kung AW, Lam KS 2005 Total thyroidectomy replaces subtotal thyroidectomy as the preferred surgical treatment for Graves' disease. ANZ J Surg 75:528-531.
6. Patwardhan NA, Moront M, Rao S, Rossi S, Braverman LE 1993 Surgery still has a role in Graves' hyperthyroidism. Surgery 114:1108-1112; discussion 12-13.
7. Kraimps JL, Bouin-Pineau MH, Mathonnet M, De Calan L, Ronceray J, Visset J, Marechaud R, Barbies J 2000 Multicentre study of thyroid nodules in patients with Graves' disease. Br J Surg 87:1111-1113.
8. Hales IB, McElduff A, Crummer P, Clifton-Bligh P, Delbridge L, Hoschl R, Poole A, Reeve TS, Wilmshurst E, Wiseman J 1992 Does Graves' disease or thyrotoxicosis affect the prognosis of thyroid cancer? J Clin Endocrinol Metab 75:886-889.
9. Stice RC, Grant CS, Gharib H, van Heerden JA 1984 The management of Graves' disease during pregnancy. Surg Gynecol Obstet 158:157-160.
10. Witte J, Goretzki PE, Roher HD 1997 Surgery for Graves' disease in childhood and adolescence. Exp Clin Endocrinol Diabetes 105:58-60.
11. Torring O, Tallstedt L, Wallin G, Lundell G, Ljunggren JG, Taube A, Saaf M, Mamberger B 1996 Graves' hyperthyroidism: treatment with antithyroid drugs, surgery, or radioiodine-a prospective, randomized study. Thyroid Study Group. J Clin Endocrinol Metab 81:2986-2993.
12. Bonnema SJ, Bartalena L, Toft AD, Hegedus L 2002 Controversies in radioiodine therapy: relation to ophthalmopathy, the possible radioprotective effect of antithyroid drugs, and use in large goitres. Eur J Endocrinol 147:1-11.
13. Dralle H 1999 Current status of total thyroidectomy in thyroid-associated orbitopathy. Exp Clin Endocrinol Diabetes 107:S195-S197.
14. Gwinup G, Elias AN, Ascher MS 1982 Effect on exophthalmos of various methods of treatment of Graves' disease. JAMA 247:2135-2138.
15. Franklyn JA, Maisonneuve P, Sheppard M, Betteridge J, Boyle P 1999 Cancer incidence and mortality after radioiodine treatment for hyperthyroidism: a population-based cohort study. Lancet 353:2111-2115.
16. Dealey C 2005 The factors that influence patients' choice of hospital and treatment. Br J Nutr 14:576-579.
17. Ren CJ, Cabrera I, Rajaram K, Fielding GA 2005 Factors influencing patient choice for bariatric operation. Obes Surg 15:202-206.